Products on this list have been selected as they are of interest for a joint HTA only or combined with a joint negotiation to three or more countries within Beneluxa. The list draws from the work under IHSI high impact reports and ongoing products under the scope of the EU HTA...
The Beneluxa Initiative aims to ensure sustainable access
to innovative medicine at affordable cost for our patients.
The Beneluxa Initiative identified impactful medicines suitable for joint HTA submission
Steering Committee Meeting and General Assembly of the Beneluxa Initiative in Dublin, Ireland
On 13 and 14 January 2026, Ireland kindly hosted representatives of the Beneluxa Initiative in Dublin for the biannual Steering Committee Meeting and the annual General Assembly. The meetings provided an opportunity for member states to take stock of current work, discuss current...
Beneluxa Initiative Appoints First General Manager
The Beneluxa Initiative is pleased to announce the appointment of Dr. Michal Stanak as its first General Manager. In this newly established role, the General Manager will support the ongoing operations of the initiative, work in close collaboration with the Domain Task Forces and...